Torsten Pietsch

42.1k citations

399 papers · 19.3k indexed · 6 hit papers · h-index 68

Genetics top 0.01%
- Glioma Diagnosis and Treatment 236
Cancer Research top 0.2%
- Cancer Genomics and Diagnostics 29
Neurology top 0.2%
- Neuroblastoma Research and Treatments 69
Molecular Biology top 0.5%
- Hedgehog Signaling Pathway Studies 56
- Chromatin Remodeling and Cancer 42
- Epigenetics and DNA Methylation 39
Pulmonary and Respiratory Medicine top 0.5%
- Brain Metastases and Treatment 36
Epidemiology
- Meningioma and schwannoma management 31

Co-authors: Andreas von Deimling Guido Reifenberger Michael Weller Matthias Simon Otmar D. Wiestler Monika Warmuth‐Metz Andreas Waha Gabriele Schackert
Cited by: Genetics Cancer Research Neurology
Journals: Neuro-Oncology (37 papers)International Journal of Cancer (28 papers)Journal of Neuro-Oncology (27 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Torsten Pietsch

383 papers receiving 19.1k citations

Hit Papers

6 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2010 Acta Neuropathologica
2009 Journal of Clinical Oncology
2008 Neurosurgery
2007 Brain
2005 New England Journal of Medicine
2002 Molecular and Cellular Biology

Peers

Countries citing papers authored by Torsten Pietsch

Since Specialization

Citations

This map shows the geographic impact of Torsten Pietsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torsten Pietsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torsten Pietsch more than expected).

Fields of papers citing papers by Torsten Pietsch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torsten Pietsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torsten Pietsch. The network helps show where Torsten Pietsch may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Torsten Pietsch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Torsten Pietsch Line = papers co-authored together Torsten Pietsch links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Medulloblastoma in children with Fanconi anemia: Association with FA-D1/FA-N, SHH type and poor survival independent of treatment strategies Neuro-Oncology ·G. Jacobs,Denise Obrecht,Pablo Hernáiz Driever,Axel Sauerbrey,Norbert Graf,Udo Kontny,Christian Reimann,福本みちよ,Uwe Kordes,Rudolf Schwarz,Tobias Obser,Felix Boschann,Ulrich Schüller,آتیه قربان پور,Tobias Goschzik,Torsten Pietsch,Martin Mynarek,Stefan Rutkowski	2024	1
2	Radiation Therapy Plays an Important Role in the Treatment of Atypical Teratoid/Rhabdoid Tumors: Analysis of the EU-RHAB Cohorts and Their Precursors International Journal of Radiation OncologyBiologyPhysics ·Sabine Frisch,植松宏彰,Sarah E. Peters,Joachim Gerß,Katja von Hoff,Rolf‐Dieter Kortmann,Karolina Nemes,Stefan Rutkowski,Martin Hasselblatt,Torsten Pietsch,Michael C. Frühwald,Beate Timmermann	2024	2
3	Preclinical evidence for the use of anti‐Trop‐2 antibody‐drug conjugate Sacituzumab govitecan in cerebral metastasized castration‐resistant prostate cancer Cancer Medicine ·Zhongguang Wen,Zuowei Fu,Hueder De Oliveria,Sadna Isik,Damian J. Ralser,Marieta Toma,Glen Kristiansen,Oliver Hahn,Sabrina Zechel,Viktor Grünwald,Tobias Bald,Ana Paula de Paula Camargo Camargo,Torsten Pietsch,Manuel Ritter,Tan Ai,Markus Eckstein,Tao Guo,Philipp Krausewitz,Niklas Klümper	2024	3
4	Adaption of neurosurgical resection patterns for pediatric low‐grade glioma spanning two decades—Report from the German LGG‐studies 1996–2018 Cancer Medicine ·政範船越,Ulrich‐Wilhelm Thomale,Daniela Kandels,Martin U. Schuhmann,Ahmed El Damaty,Jürgen Krauß,Michael C. Frühwald,Pablo Hernáiz Driever,Olaf Witt,Brigitte Bison,Monika Warmuth‐Metz,Torsten Pietsch,René Schmidt,Astrid Gnekow	2024	0
5	Melanoma Brain Metastases Patient-Derived Organoids: An In Vitro Platform for Drug Screening Pharmaceutics ·純西川,Guleena Junaid,Andreas Waha,Gerrit H. Gielen,清次山口,Motaz Hamed,Erdem Güresir,Anne Fröhlich,Judith Sirokay,Tacbir Hendro Pudjiantoro,Glen Kristiansen,Torsten Pietsch,Hartmut Vatter,Tan Ai,Matthias Schneider,Marieta Toma	2024	2
6	Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytoma Acta Neuropathologica ·Michael Weller,Jörg Felsberg,Bettina Hentschel,Dorothee Gramatzki,wang shaoping,Marietta Wolter,Sedsel Kristine Stage Pedersen,Patrick Roth,Dietmar Krex,Ulrich Herrlinger,Manfred Westphal,J. C. Tonn,Luca Regli,Claude‐Alain Maurage,Andreas von Deimling,Torsten Pietsch,Émilie Le Rhun,Guido Reifenberger	2024	27
7	508MO Spatial remodeling of the immune tumor microenvironment after radiotherapy and CXCL12 inhibition in glioblastoma in the phase I/II GLORIA trial Annals of Oncology ·Masayoshi ICHINOE,Julian Philipp Layer,Alexander M. Douglas,宋永春,Hong-Xia Liang,Dillon Corvino,Christina Schaub,William J. Muller,Elena Sperk,Leonard Christopher Schmeel,Renée Morissette,Sied Kebir,Sancini Giulio,Torsten Pietsch,Kevin Thurley,Martin Glas,Clemens Seidel,Ulrich Herrlinger,Frank A. Giordano,Nurul Ain Binti Adnan	2023	1
8	DNA methylation profiling improves routine diagnosis of paediatric central nervous system tumours: A prospective population‐based study Neuropathology and Applied Neurobiology ·Doua Philemon,T Kovats,Torsten Pietsch,Thomas Olsson Bontell,Teresia Kling,Anna Wenger,Sandra Ferreyra Vega,Anna Danielsson,Sándor Dósa,Stefan Holm,Rob Hurley,Per Olof Nyman,Amenah Bashara,Per‐Erik Sandström,Stefan M. Pfister,Birgitta Lannering,Magnus Sabel,Helena Carén	2022	16
9	Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trial Neuro-Oncology ·M M Nathalie Barreto,Marco Gessi,Nicolas U. Gerber,Carsten Friedrich,Martin Mynarek,André O. von Bueren,Christine Haberler,Ulrich Schüller,Rolf‐Dieter Kortmann,Beate Timmermann,Brigitte Bison,Monika Warmuth‐Metz,Robert Kwiecien,Stefan M. Pfister,Claudia Spix,Torsten Pietsch,Marcel Kool,Stefan Rutkowski,Katja von Hoff	2021	9
10	The FDA approved PI3K inhibitor GDC‐0941 enhances in vitro the anti‐neoplastic efficacy of Axitinib against c‐myc‐amplified high‐risk medulloblastoma Journal of Cellular and Molecular Medicine ·Michael Ehrhardt,Rogerio B. Craveiro,Julia Velz,G. Rutkowski,Anna Casati,Stefan Schönberger,Torsten Pietsch,Dagmar Dilloo	2018	13
11	Dual Blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) Pathways Synergistically Inhibits Rhabdomyosarcoma Cell Growth In Vitro and In Vivo Clinical Cancer Research ·Jane Renshaw,Kathryn R. Taylor,Ryan T. Bishop,Melanie Valenti,Alexis de Haven Brandon,Sharon Gowan,Suzanne A. Eccles,Ruth Ruddle,Louise D. Johnson,Florence I. Raynaud,Joanna Selfe,Khin Thway,Torsten Pietsch,Andrew D.J. Pearson,Janet Shipley	2013	110
12	Long-Term Survival in Primary Glioblastoma With Versus Without Isocitrate Dehydrogenase Mutations Clinical Cancer Research ·Christian Hartmann,Bettina Hentschel,Matthias Simon,Manfred Westphal,Gabriele Schackert,Jörg C. Tonn,Markus Loeffler,Guido Reifenberger,Torsten Pietsch,Andreas von Deimling,Michael Weller,(unknown)	2013	138
13	Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma Journal of Clinical Oncology ·Roger Stupp,Monika E. Hegi,Bart Neyns,Roland Goldbrunner,Uwe Schlegel,Paul M. Clément,Gerhard G. Grabenbauer,Adrian F. Ochsenbein,Matthias Simon,Pierre-Yves Dietrich,Torsten Pietsch,Christine Hicking,Joerg-Christian Tonn,Edita Kapus,Alessia Pica,Mirjam Hermisson,Stefan Krueger,Martin Picard,Michael Weller	2010	341
14	Epigenetic Downregulation of Mitogen-Activated Protein Kinase Phosphatase MKP-2 Relieves Its Growth Suppressive Activity in Glioma Cells Cancer Research ·Anke Waha,Jörg Felsberg,Wolfgang Hartmann,Gonzalo Espuela Sánchez,Thomas Mikeska,Stefan Joos,Marietta Wolter,Arend Koch,Pearlly S. Yan,Elmar Endl,Otmar D. Wiestler,Guido Reifenberger,Torsten Pietsch,Andreas Waha	2010	67
15	Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network Journal of Clinical Oncology ·Michael Weller,Jörg Felsberg,Christian Hartmann,Hilmar Berger,Joachim P. Steinbach,Johannes Schramm,Manfred Westphal,Gabriele Schackert,Matthias Simon,Jörg C. Tonn,Oliver Heese,Dietmar Krex,Guido Nikkhah,Torsten Pietsch,Otmar D. Wiestler,Guido Reifenberger,Andreas von Deimling,Markus Loeffler	2009	476
16	Activation of Phosphatidylinositol-3′-kinase/AKT Signaling Is Essential in Hepatoblastoma Survival Clinical Cancer Research ·Wolfgang Hartmann,Jan Küchler,Arend Koch,Nicolaus Friedrichs,Anke Waha,Elmar Endl,Karl Bosch,Dagmar Metzger,Susanne Steiner,Peter Wurst,Ivo Leuschner,Dietrich von Schweinitz,Reinhard Buettner,Torsten Pietsch	2009	67
17	NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomidebreakdown → Journal of Clinical Oncology ·Wolfgang Wick,Christian Hartmann,Corinna Engel,Mandy Stoffels,Jörg Felsberg,Florian Stockhammer,Michael Sabel,Susanne Koeppen,Ralf Ketter,Richard Meyermann,Marion Rapp,C Meisner,Rolf D. Kortmann,Torsten Pietsch,Otmar D. Wiestler,Ulrike Ernemann,Michael Bamberg,Guido Reifenberger,Andreas von Deimling,Michael Weller	2009	571
18	Human medulloblastomas lack point mutations and homozygous deletions of the hSNF5/INI1 tumour suppressor gene Neuropathology and Applied Neurobiology ·J. Kraus,真二大井,N. Sörensen,Frank Berthold,Uwe Schlegel,J.-C. Tonn,O. D. Wiestler,Torsten Pietsch	2002	18
19	Hepatocyte growth-factor-scatter factor can stimulate post-operative tumor-cell proliferation in childhood hepatoblastoma International Journal of Cancer ·Dietrich von Schweinitz,A Santhoshkumar,Birgit Teichmann,Tobias Birnbaum,Arend Koch,Hartmut Hecker,S. Glüer,Jörg Fuchs,Torsten Pietsch	2000	50
20	A Rapid and Sensitive Protocol for Competitive Reverse Transcriptase (cRT) PCR Analysis of Cellular Genes Brain Pathology ·Andreas Waha,Matthias Watzka,Anke Koch,Torsten Pietsch,René Przkora,Nils Peters,Otmar D. Wiestler,Andreas von Deimling	1998	43

About Torsten Pietsch

Torsten Pietsch is a scholar working on Genetics, Neurology and Structural Biology, having authored 399 papers that have together received 19.3k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (236 papers), Neuroblastoma Research and Treatments (69 papers), Hedgehog Signaling Pathway Studies (56 papers), Chromatin Remodeling and Cancer (42 papers), Epigenetics and DNA Methylation (39 papers), Brain Metastases and Treatment (36 papers), Meningioma and schwannoma management (31 papers) and Cancer Genomics and Diagnostics (29 papers). The work is most often cited by research in Genetics (9.9k citations), Cancer Research (3.4k citations) and Neurology (3.2k citations). Torsten Pietsch has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Andreas von Deimling, Guido Reifenberger, Michael Weller, Matthias Simon, Otmar D. Wiestler, Monika Warmuth‐Metz, Andreas Waha, Gabriele Schackert, Stefan Rutkowski and Dietrich von Schweinitz. Their work appears in journals such as Neuro-Oncology, International Journal of Cancer, Journal of Neuro-Oncology, Journal of Clinical Oncology and Acta Neuropathologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact